FDA Investigator Emily S Mcgann
Emily S Mcgann has inspections in 1 countries as of 21 Sep 2023. Emily S Mcgann has collaborated with a combined 1383 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
31
Last Inspection Date:
21 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Abby Lmozeke Baker,
Adam J Taylor,
Albert F Peacock, PhD,
Ana Djurdjevic,
Ana L Kewes,
Anthony N Onianwa,
Anya D Lockett Evans,
Armando Chavez, MS,
Arsen Karapetyan,
Blondell W Johnson,
Bryce A May,
Charles L Larson,
Connie L Hannon Rabel,
Darla J Christopher,
Decarlos A Gomez,
Denise L Burosh,
Diana L Ayala,
Diana M Rand,
Ellen C Weisensel,
Elmina E Akwo,
Elmina E Mboh,
Ernest Serna, III,
Everard A Irish,
Gabriel M Guevarra,
Garrad R Poole,
Gene D Arcy,
Gloria A Milster,
Hoimay Chan,
Humera T Khan,
Jennifer C Adams,
Jennifer C Johnson,
Jesse P Romenesko,
Jocelyn C Turner,
Justin A Boyd,
Ka L Wong,
Kelly D Moore,
Kenneth S Boehnen,
Kip J Hanks,
Laurissa S Flowers,
Lillie M Young,
Lorie S Hannappel,
LTJG Bradley E Benasutti,
Maira P Brading,
Marion W Nadeau,
Mary Ann Ruff,
Matthew J Gretkierewicz,
Melissa D Kalik,
Melissa J Holz,
Michael I Gorman,
Michael N Roberts,
Michelle J Glembin,
Monique S Frazier,
Nathan R Moon,
Patricia M Jacobs,
Paul M Chefor,
Robert M Tillman,
Robert S Sweeton,
Roberta W Cunningham,
Ronda R Loyd Jones,
Rose M Ashley,
Rosia E Nesbitt,
Sarah A Palmer,
Shalonda C Clifford,
Sunitha K Rajaram, PhD,
Susan M Miller,
Susan M North,
Tawny L Colling,
Terrance L Thomas,
Thanh B Tran,
Toby Vern H Hill,
Tonia L Sawyer,
Travis R Hunt,
Vanessa R Muller,
William F Lagud, Jr,
Young M Yoon,
Yvonne C Wilkes,
Yvonne E Lozano,
Yvonne T Lacour,
Zerita White
Emily S Mcgann's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more